1 ML burosumab-twza 20 MG/ML Injection [Crysvita]

RxNorm concept 2043870, branded drug (sbd). Prescribable name: CRYSViTA 20 MG in 1 ML Injection.

RxCUI: 2043870
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2043870 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

burosumab 2043855

Other names

Crysvita 20 MG per 1 ML Injection

Related concepts

burosumab-twza 20 MG/ML (SCDC, consists of)
burosumab-twza 20 MG/ML [Crysvita] (SBDC, consists of)
Injection (DF, has dose form)
Crysvita (BN, has ingredient)
1 ML burosumab-twza 20 MG/ML Injection (SCD, tradename of)

Linked data

NDCs

42747020301
69794020301

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2043870 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2043870 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2043870. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.